At Eurofins, we recognise the growing need for accurate, science-driven information around performance-enhancing substances. Safe Pulse is creating a new synthesis by combining clinical insight with real-world community practice, alongside safety awareness and education in an ever-evolving landscape that includes regenerative and performance medicine. This much-needed, improved perspective on harm reduction ensures individuals have access to clear, evidence-based guidance — empowering safer decisions and better long-term, health-focused outcomes. Our academic, medical, and support teams are proud to be part of this initiative and ongoing research.
George Worthington
Operations Director for Clinical Diagnostics UK @ Eurofins












